User uploaded custom header image
Category results for: B. Frank Gupton

VCU Engineering’s Medicines for All Institute partners with industry to secure the domestic pharmaceutical supply chain

To prevent domestic shortages of critical medications, the Medicines for All Institute, based in the Virginia Commonwealth University College of Engineering, has joined forces with pharmaceutical industry leaders to bring manufacturing of vulnerable pharmaceuticals and their ingredients back to the United States.

VCU Engineering students, alumni honored in NSF graduate fellowship program

Two VCU Engineering students and two alumni have received recognition in the highly prestigious National Science Foundation’s (NSF’s) Graduate Research Fellowship Program.

Innovative faculty recognized by the VCU chapter of the National Academy of Inventors

Faculty innovators help empower Virginia Commonwealth University to respond to pressing social needs, VCU President Michael Rao told members of the VCU chapter of the National Academy of Inventors.

Collaboration with one-of-a-kind drug production lab at VCU accelerates Massey’s innovation

For the better part of a decade, Clevenger was incapable of furthering this investigation because there was no way he could acquire this drug. Now, he will finally be able to continue this research thanks to a new Massey collaboration with a world-class drug synthesis laboratory at Virginia Commonwealth University.

More than 30 Ram Engineers featured in VCU alumni magazine’s ‘Power Issue’

VCU Engineering is all over the latest issue of Shafer Court Connections, VCU’s alumni magazine.

VCU Engineering’s Medicines for All awarded $25 million to increase access to lifesaving medications

The Virginia Commonwealth University School of Engineering has been awarded a $25 million grant from the Bill & Melinda Gates Foundation to establish the Medicines for All Institute and to fund the institute’s work on a wide range of essential global health treatments. With this grant, the institute can help increase access to lifesaving medications for HIV/AIDS, malaria, tuberculosis and other diseases around the world.

Medicines for All team set to save lives globally

By Leila UginciusUniversity Public Affairs One time while visiting family in his native Benin, Perrer Tosso, Ph.D., became sick and went to the pharmacy to buy ciprofloxacin, the antibiotic more commonly known as Cipro. The exorbitant amount he paid didn’t line up with the price he would normally pay in the United States where he has […]

Medicines for All Initiative funded for third AIDS therapy

The Medicines for All Initiative has received approximately $5 million from the Bill & Melinda Gates Foundation to develop a more cost-effective way to manufacture Dolutegravir, a new HIV/AIDS therapy. The Initiative’s lead investigator is B. Frank Gupton, Ph.D., professor and chair in the Virginia Commonwealth University Department of Chemical & Life Science Engineering. “[Dolutegravir] […]

« Previous Page